Results 201 to 210 of about 214,937 (381)

CLINICAL STUDIES ON CHRONIC GASTRITIS

, 1980
Taidoh Arai
openalex   +2 more sources

Changes in Eating Behaviour During Treatment With Obesity Medications

Clinical Obesity, Volume 16, Issue 1, February 2026.
ABSTRACT Obesity is a chronic, relapsing disease influenced by biological, environmental and behavioural factors. Pharmacological therapies have demonstrated substantial effects in weight loss, appetite suppression and modulation of food‐related thoughts; however, the long‐term effects of medications and eating behaviours across treatment phases ...
Ming Chuen Chong, Tak Ying Louise Ko, Philippus L. le Roux, Carel W. le Roux   +3 more
wiley   +1 more source

Diagnostic value of combined detection of pepsinogen, gastrin-17, and ¹³C-urea breath test in Helicobacter pylori-associated chronic gastritis in children: a multivariate analysis. [PDF]

Front Pediatr
Gao Y, Liu C, Ouyang K, Li S, Huang W.
europepmc   +1 more source

Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication ‐ a prospective study for up to 10 years

Alimentary Pharmacology and Therapeutics, 2018
Y. Hwang, Nayoung Kim, Nayoung Kim, H. Lee, Jaebong Lee, Y. Choi, H. Yoon, C. Shin, Y. Park, Duckey Lee, Duckey Lee   +10 more
semanticscholar   +1 more source

PIONEER REAL Saudi Arabia: A multicentre, prospective, real‐world study of once‐daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1304-1314, February 2026.
Abstract Aim PIONEER REAL Saudi Arabia investigated real‐world clinical outcomes associated with the use of once‐daily oral semaglutide in adults with type 2 diabetes (T2D). Materials and Methods This was a 34‐ to 44‐week multicentre, prospective, open‐label study in adults with T2D, who were treatment‐naive to injectable glucose‐lowering medication ...
Hussein ElBadawi, Nader Albalkhi, Ibrahim Al Kadhim, Ahmed Elsadig, Dimitrios Baltzis, Mohamed Hassan Hatahet, Mahmoud Ismail, Said Khader, Christina Louise Rasmussen, Stine Hedegaard Scheuer, Ahmed Shalaby, Mohammed Almehthel   +11 more
wiley   +1 more source

Concordance of the rapid urease test and the histopathology report in detecting <i>Helicobacter pylori</i> infection in a bariatric population. A retrospective cohort study. [PDF]

Prz Gastroenterol
Panek P, Rymarowicz J, Czeliński M, Pośpiech J, Dembiński M, Winiarski M, Major P, Kukla M.   +7 more
europepmc   +1 more source

In-vivo evaluation of apocynin for prevention of Helicobacter pylori-induced gastric carcinogenesis [PDF]

, 2017
Akagi, Allen, Arora, Ayala, Barnes, Cadamuro, Castor, Chandan, Connell, Conway, de Almeida, Dunn, Elfvin, Eruslanov, Ghosh, Guang, Gustavson, Handa, Hardbower, Harsha, Hougee, Kennett, Lafeber, Lull, Malfertheiner, McManus, Mózsik, Müller, Pedroso, Philippens, Rodriguez, Rubin, Stefanska, Stefanska, Tang, Umamaheshwari, Wang, Wiedemann, Xu, Yamazaki, Zhang, Zhao   +41 more
core   +2 more sources

Risk of primary sclerosing cholangitis among patients with gastritis: a nationwide cohort study [PDF]

Lina Lindström Älgå, Isabella Ekheden, Marcus Thuresson, Jonas F. Ludvigsson   +3 more
openalex   +1 more source

Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists for incident dementia: A retrospective multicohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1443-1452, February 2026.
Abstract Objective This study provides real‐world evidence on the comparative effectiveness of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) regarding the risk of incident dementia in adults with type 2 diabetes mellitus (T2DM).
Filippos Anagnostakis, Michail Kokkorakis, Shrihari Nagarajan, Georgia Anastasiou, Christos S. Mantzoros   +4 more
wiley   +1 more source

Immunotherapy-Related Gastritis in Small Cell Lung Cancer Treatment With Durvalumab-A Case Report. [PDF]

Cancer Rep (Hoboken)
Cavaliere MC, Spadafora S, Febbraro M.
europepmc   +1 more source